This week in Cubist Pharmaceuticals, Inc. v. Hospira, Inc., Supr. Ct. No. 15-1210, the Supreme Court is scheduled to vote whether to grant certiorari on the issue of secondary considerations ...
Monday morning (May 23, 2016), the Supreme Court may announce whether it has granted certiorari inDow Chemical Co. v. Nova Chemicals Corp. (Canada), Supr.Ct. No. 15-1160, proceedings below, 803 F.3d ...
Looking ahead to the 2016 Term of the Court that runs through June 2017, seven of the Top Ten Patent Cases are selected in the attached abbreviated list which considers cases ...
By now, most patent practitioners have a fairly sophisticated understanding of the “new” (five year old) patent law, the Leahy Smith America Invent Act. Everyone knows that it is very ...
In Top Ten No. (7) Life Techs. Corp. v. Promega Corp., Supreme Court No. 14-1538, the Solicitor General has now filed his CVSG amicus brief. He recommends that the Court ...
Enfish, LLC v. Microsoft Corp., __ F.3d __ (Fed. Cir. May 12, 2016)(Hughes, J.), is a an important decision dealing with software patent-eligibility, but only because it is a rare ...
Stanford University Law School Professor Mark A. Lemley’s impressive amicus brief in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., Fed. Cir. 2016-1284, was noted earlier today, contrasted with the ...
Esteemed Stanford University Law School Professor Mark A. Lemley has produced an impressive amicusbrief in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., Fed. Cir. 2016-1284. Professor Lemley argues that ...
The previous note (attached) focuses on what's neither in the Rules of Practice in Patent Cases, the Manual of Patent Examining Procedure nor the mammoth AIPLA treatise cited in the ...
In the five years since the Leahy Smith America Invents Act became law, many Americans have adapted to the new reality of first-to-file. Yet, theRules of Practice in Patent Cases ...